Urinary System Adenocarcinoma — Trials

Urinary System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 379
Recruiting: 195
Ph III recruiting: 14
Growth YoY: +2.5%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (279)

clinicaltrialsPublishedShowing 351–400 of 1,630 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07460206	Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment(PRELUDE)	not yet recruiting	Phase 2	108	Gruppo Oncologico Italiano di Ricerca ClinicaOTHER	0	Mar 10, 2026	clinicaltrials
NCT04792463	Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome	recruiting	—	500	Mohamed Abdel-RahmanOTHER	1	Mar 9, 2026